Earnings
ARMP
5.69
-1.10%
-0.06
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
6.03M
--
--
--
--
--
0.00
--
--
--
622.00K
--
6.66M
4.21M
--
--
--
3.49M
10.26M
--
835.00K
18.80M
25.45M
--
547.00K
0.00
--
--
--
--
--
3.36M
--
--
--
970.00K
4.88M
0.00
--
--
3.08M
2.90M
5.98M
10.86M
99.00K
172.01M
-157.52M
--
--
--
14.59M
14.59M
25.45M
FY 2018-12-31
8.16M
--
--
--
--
--
0.00
--
--
--
251.00K
--
8.41M
503.00K
--
--
--
--
2.98M
--
--
3.48M
11.89M
--
729.00K
0.00
--
--
--
--
--
1.80M
--
--
--
38.00K
2.57M
0.00
--
--
819.00K
22.00K
841.00K
3.41M
323.00K
414.47M
-406.32M
--
--
--
8.47M
8.47M
11.89M
FY 2017-12-31
5.13M
--
--
--
--
--
0.00
--
--
--
253.00K
--
5.38M
816.00K
--
--
--
--
4.94M
--
--
5.75M
11.14M
--
578.00K
0.00
--
--
--
302.00K
--
1.35M
--
--
--
38.00K
1.97M
0.00
--
--
1.15M
292.00K
1.44M
3.41M
95.00K
401.84M
-394.21M
--
--
--
7.73M
7.73M
11.14M
FY 2016-12-31
5.71M
--
--
12.00K
--
--
0.00
--
--
--
602.00K
--
6.31M
1.07M
--
--
--
--
10.77M
--
--
11.84M
18.15M
--
1.06M
803.00K
--
--
--
746.00K
--
1.64M
--
--
--
38.00K
3.54M
0.00
--
--
2.45M
2.44M
4.89M
8.43M
16.00K
391.07M
-381.36M
--
--
--
9.72M
9.72M
18.15M
FY 2015-12-31
9.37M
--
--
125.00K
--
--
0.00
--
--
--
521.00K
--
10.02M
1.13M
--
--
--
7.56M
12.78M
--
--
21.48M
31.49M
--
--
0.00
--
--
--
1.46M
--
308.00K
--
--
--
613.00K
2.38M
0.00
--
--
3.00M
1.50M
4.50M
6.89M
59.00K
375.18M
-362.52M
--
--
--
24.60M
24.60M
31.49M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ARMP latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Armata Pharmaceuticals Inc recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.